```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 10085 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                               H. R. 10085

   To require that opioid overdose rescue kits be located at public 
       institutions of higher education, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            November 1, 2024

 Ms. De La Cruz (for herself and Mr. Correa) introduced the following 
    bill; which was referred to the Committee on Education and the 
Workforce, and in addition to the Committee on Energy and Commerce, for 
a period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL

 
   To require that opioid overdose rescue kits be located at public 
       institutions of higher education, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Saving Lives on Campuses Act of 
2024''.

SEC. 2. OPIOID OVERDOSE RESCUE KIT REQUIRED.

    (a) In General.--Not later than 1 year after the date of the 
enactment of this Act, the Secretary of Education, in consultation with 
the Secretary of Health and Human Services, shall require each public 
institution of higher education that receives funds under the Higher 
Education Act of 1965 (20 U.S.C. 1001 et seq.) to make available opioid 
overdose rescue kits in accordance with subsection (b).
    (b) Location.--
            (1) In general.--An opioid overdose kit required under 
        subsection (a) shall be--
                    (A) available in each classroom facility, library, 
                laboratory facility, dormitory (including dining 
                facilities), or other facility customarily used by an 
                institution for instructional or research purposes or 
                for housing students, faculty, and staff;
                    (B) in the case of a facility described in 
                subparagraph (A) that has an automated external 
                defibrillator for public use, placed, where feasible, 
                near such automated external defibrillator; and
                    (C) on the person of each individual employed by 
                the institution as emergency medical services 
                personnel, as applicable.
            (2) Registration.--The location of each opioid overdose 
        rescue kit required under subsection (a) shall be registered 
        with the health center of the institution or campus emergency 
        medical services, as applicable.
    (c) Additional Requirements.--Each institution shall--
            (1) replace used or expired opioid overdose rescue kits 
        located on the campus of the institution, as necessary;
            (2) make available, through the health center of the 
        institution or campus emergency medical services, as 
        applicable, a list of locations of each opioid overdose rescue 
        kit; and
            (3) provide training regarding the use and location of each 
        opioid overdose rescue kit during each student orientation 
        program carried out by the institution.
    (d) Definitions.--In this section:
            (1) Institution of higher education.--The term 
        ``institution of higher education'' has the meaning given the 
        term in section 102 of the Higher Education Act of 1965 (20 
        U.S.C. 1002).
            (2) Opioid overdose rescue kit.--The term ``opioid overdose 
        rescue kit'' means a kit that--
                    (A) is labeled with the words ``Overdose Rescue 
                Kit--Naloxone Nasal Spray'' or other language approved 
                by the Secretary of Health and Human Services; and
                    (B) includes--
                            (i) Narcan;
                            (ii) naloxone; or
                            (iii) another medication approved by the 
                        Food and Drug Administration that, when 
                        administered, negates or neutralizes, in whole 
                        or in part, the pharmacological effects of an 
                        opioid in the human body.
                                 <all>
```